| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $112.80 | $25.49 | 342.57% | 212.83x | 53.68x | 14.31x | 17.28x | 1.54x | $106.92M | 0.90% | $705.78M | 6.70 | $12.09B | 1,541.35 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.66 | $8.67 | 172.93% | 112.67x | 55.02x | 6.66x | 13.48x | 0.97x | $39.15M | 1.27% | $220.58M | 1.69 | $3.05B | 67.27 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $264.50 | $84.06 | 214.65% | 43.36x | 38.99x | 7.36x | 26.14x | 1.53x | $793.95M | 2.25% | $1.35B | 10.14 | $36.67B | 31.09 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $80.47 | $18.36 | 338.23% | 75.21x | 68.84x | 7.42x | 9.60x | 1.92x | $182.84M | 2.93% | $654.15M | 8.43 | $6.11B | 50.95 | ||
| RPRX | ROYALTY PHARMA PLC | $63.88 | $38.18 | 67.32% | 33.98x | 11.93x | 11.21x | 3.75x | 0.69x | $2.92B | 10.28% | $9.79B | 21.99 | $44.88B | 38.16 | ||
| VCEL | VERICEL CORP | $40.47 | $8.48 | 377.45% | 84.31x | 72.31x | 6.75x | 5.60x | 2.07x | $61.66M | 2.98% | $370.04M | 7.25 | $2.04B | 46.30 | ||
| HALO | HALOZYME THERAPEUTICS INC | $110.76 | $71.98 | 53.87% | 31.11x | 12.26x | 7.81x | 87.58x | 0.64x | $806.22M | 6.21% | $143.54M | 1.22 | $14.55B | 20.26 | ||
| KRYS | KRYSTAL BIOTECH INC | $371.47 | $89.37 | 315.68% | 44.92x | 47.59x | 24.90x | 8.09x | 2.38x | $257.78M | 2.35% | $1.36B | 46.03 | $10.58B | 45.34 | ||
| TGTX | TG THERAPEUTICS INC | $56.71 | $23.77 | 138.58% | 18.41x | 57.06x | 10.05x | 14.37x | 2.05x | $17.39M | 0.22% | $604.08M | 4.26 | $8.95B | 64.28 | ||
| TECH | BIO-TECHNE CORP | $72.45 | $17.37 | 317.07% | 61.92x | 34.70x | 9.30x | 5.39x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.75 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.43 | $19.97 | 232.66% | 174.82x | 22.81x | 3.77x | 2.03x | 1.15x | $738.18M | 5.74% | $6.32B | 32.68 | $16.17B | 41.93 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.54 | $8.07 | 55.40% | 13.20x | 11.53x | 5.45x | 3.42x | 1.15x | $82.01M | 11.05% | $217.65M | 3.68 | $600.85M | 7.77 | ||
| ADMA | ADMA BIOLOGICS INC | $9.58 | $7.40 | 29.49% | 13.31x | 12.04x | 4.27x | 5.26x | 0.78x | $116.47M | 5.32% | $408.21M | 1.79 | $2.21B | 9.47 | ||
| EXEL | EXELIXIS INC | $59.13 | $31.77 | 86.14% | 17.97x | 17.91x | 6.09x | 7.95x | 1.18x | $1.17B | 7.91% | $1.84B | 7.35 | $14.54B | 13.36 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $289.74 | $91.11 | 218.00% | 28.77x | 30.67x | 20.01x | 5.97x | 2.17x | $130.62M | 2.25% | $967.52M | 48.22 | $5.90B | 21.15 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $247.57 | $188.72 | 31.18% | 16.22x | 9.69x | 3.40x | 3.35x | 0.68x | $1.62B | 10.35% | $4.80B | 75.98 | $18.85B | 11.66 | ||
| MDXG | MIMEDX GROUP INC | $4.43 | $1.51 | 193.14% | 110.75x | -31.58x | 1.84x | 2.99x | 1.05x | $44.50M | 6.79% | $216.00M | 1.46 | $527.09M | 23.11 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.30 | -80.64% | 8.71x | -4.12x | 1.50x | 1.61x | 0.07x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $557.96 | $161.35 | 245.82% | 32.20x | 29.03x | 11.25x | 6.98x | 2.29x | $3.80B | 2.68% | $20.25B | 79.81 | $137.26B | 24.94 | ||
| UTHR | UNITED THERAPEUTICS CORP | $490.24 | $203.12 | 141.36% | 16.21x | 18.30x | 6.62x | 3.29x | 2.80x | $1.09B | 5.23% | $6.40B | 150.24 | $19.22B | 11.47 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $843.47 | $452.27 | 86.50% | 20.11x | 15.12x | 5.58x | 2.74x | 1.07x | $3.76B | 4.34% | $31.71B | 308.48 | $87.09B | 15.15 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.86 | $31.91 | 31.20% | 13.33x | 10.04x | 2.53x | 2.44x | 0.79x | $354.90M | 14.63% | $999.24M | 17.25 | $2.04B | 7.29 | ||
| INCY | INCYTE CORP | $128.00 | $62.46 | 104.94% | 15.76x | 36.11x | 4.41x | 4.09x | 1.77x | $1.92B | 7.49% | $6.34B | 31.66 | $21.99B | 10.64 | ||
| VCYT | VERACYTE INC | $44.67 | $7.18 | 522.19% | 31.02x | 42.73x | 6.36x | 2.59x | 123.39x | $165.99M | 4.65% | $1.39B | 17.36 | $3.33B | 23.84 |